IQVIA Human Data Science Research Collaborative Initiative Waives Data Access Fees for Academic Researchers

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–()–IQVIA™ (NYSE: IQV) introduced a brand new Human Data Science Research Collaborative initiative that’s waiving licensing and entry charges for authorized tutorial researchers around the globe to make use of two IQVIA knowledge expertise platforms and analytics from a number of international locations to speed up analysis addressing challenges and alternatives for well being techniques within the COVID-19 period.

The initiative, led by the IQVIA Institute for Human Data Science, offers authorized tutorial researchers entry to 2 of IQVIA’s knowledge expertise platforms, E360 and SMART, by way of October 2020.

  • E360 is the industry-leading SaaS expertise platform used to carry out scalable analytics throughout a worldwide portfolio of huge and sophisticated actual world knowledge. Researchers could entry, by way of E360, combination statistics derived from non-identified longitudinal affected person knowledge from the US, France, Germany and the UK.
  • SMART brings collectively the {industry}’s main syndicated data belongings onto a sturdy enterprise intelligence platform. Access to SMART will present a view into U.S. nationwide insights on prescribing, success channel, gross sales volumes, promotional and managed care market entry, in addition to medical machine and provide monitoring.

In addition, combination statistics derived from non-identified U.S. longitudinal affected person knowledge will likely be made obtainable as wanted to help particular analysis.

“The recent COVID-19 worldwide pandemic has created both immediate and long-term consequences for people and health systems around the world,” mentioned Murray Aitken, govt director of the IQVIA Institute for Human Data Science. “IQVIA aspires to join the fight against the impact of COVID-19 by applying Human Data Science to support research activities related to health system issues in collaboration with the world’s leading academic researchers. By waiving licensing and access fees, we can help accelerate evidence-based, COVID-19-related learning. We believe that the IQVIA technology platforms and analytics provide extraordinary resources for conducting collaborative research that can generate evidence and insights about the transformation of health systems in the COVID-19 era.”

Academic researchers welcome the IQVIA initiative and the help it’ll present their analysis.

G. Caleb Alexander, professor of Epidemiology and Medicine, Johns Hopkins Bloomberg School of Public Health, mentioned, “The pandemic has upended life as we know it, including health care delivery. This program offers academic researchers a unique opportunity to apply IQVIAs informational assets to address some of the biggest questions that the pandemic poses.”

Rena M. Conti, affiliate professor, Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, mentioned, “This is an incredible moment in time to ask and answer important questions that could change policy, improve clinical care and impact the global healthcare ecosystem. Our research team is taking advantage of access to IQVIA data technology platforms to investigate the demand, supply and pricing of therapeutics potentially impacted by the COVID-19 pandemic. In the interest of collaboration and knowledge-sharing, we hope to share our research findings swiftly and broadly with the global healthcare community.”

Katie J. Suda, professor of Medicine, University of Pittsburgh School of Medicine, mentioned, “The frequency, persistence and duration of drug shortages has increased dramatically over the last decade, leading to supply disruptions among thousands of drugs every year. Although the problem of drug shortages is well known, we don’t yet know the impact of drug shortages during a global emergency. However, it is clear that the 2019 Coronavirus disease pandemic has significantly impacted the drug supply chain. Assessing drug shortages during the COVID-19 pandemic based on real-time data from multiple countries will inform health policy locally and globally.”

For extra details about this IQVIA Human Data Science Research Collaborative initiative go to www.iqviainstitute.org

About the IQVIA Institute for Human Data Science

The IQVIA Institute for Human Data Science contributes to the development of human well being globally by way of well timed analysis, insightful evaluation, and scientific experience utilized to granular non-identified patient-level knowledge.

Fulfilling a necessary want inside healthcare, the Institute delivers goal, related insights and analysis that speed up understanding and innovation crucial to sound decision-making and improved human outcomes. With entry to IQVIA’s institutional data, superior analytics, expertise, and unparalleled knowledge, the Institute works in tandem with a broad set of healthcare stakeholders to drive a analysis agenda targeted on human knowledge science, together with authorities businesses, tutorial establishments, the life sciences {industry}, and payers. More details about the IQVIA Institute may be discovered at www.IQVIAInstitute.org.

About IQVIA

IQVIA (NYSE:IQV) is a number one world supplier of superior analytics, expertise options, and contract analysis companies to the life sciences {industry}. Formed by way of the merger of IMS Health and Quintiles, IQVIA applies human knowledge science — leveraging the analytic rigor and readability of information science to the ever-expanding scope of human science — to allow firms to reimagine and develop new approaches to scientific growth and commercialization, velocity innovation and speed up enhancements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers distinctive and actionable insights on the intersection of large-scale analytics, transformative expertise and intensive area experience, in addition to execution capabilities. With roughly 67,000 workers, IQVIA conducts operations in additional than 100 international locations.

IQVIA is a worldwide chief in defending particular person affected person privateness. The firm makes use of all kinds of privacy-enhancing applied sciences and safeguards to guard particular person privateness whereas producing and analyzing data on a scale that helps healthcare stakeholders establish illness patterns and correlate with the exact therapy path and remedy wanted for higher outcomes. IQVIA’s insights and execution capabilities assist biotech, medical machine and pharmaceutical firms, medical researchers, authorities businesses, payers and different healthcare stakeholders faucet right into a deeper understanding of illnesses, human behaviors, and scientific advances, in an effort to advance their path towards cures. To study extra, go to www.iqvia.com.

LEAVE A REPLY

Please enter your comment!
Please enter your name here